Treatment with EN2 protein significantly increased cell proliferation rates in all PCa cell lines analyzed (LNCaP, 22Rv1 and PC3) but not in the normal RWPE-1 cells, compared to vehicle-treated controls (Figure 2c). The gene discussed is EN2; the disease is posterior cortical atrophy.